Kit INF-005 from Biomol Laboratories used in publication on VEXAS
The study showed concordance with Sanger sequencing, confirming the effectiveness of the kit for molecular diagnosis.
See the latest news and media coverage for Biomol Laboratories. We track all announcements, press releases, and industry mentions in real time, all in one place.
Molecular biology diagnostics startup
biomollaboratories.itLast updated
In short: Biomol Laboratories launched a new molecular diagnostic kit for VEXAS Syndrome and participated in major international trade fairs.
The study showed concordance with Sanger sequencing, confirming the effectiveness of the kit for molecular diagnosis.
Elysium Cellbioita, Ceinge Biotecnologie Avanzate Franco Salvatore, and NutriGen4you will also participate.
They exchanged ideas, gathered feedback for implementation, and reinforced industry relationships. They thank participants for insights aiding growth.
The team is thrilled and excited to present their work tomorrow. They eagerly await meeting attendees there.
Track Biomol Laboratories and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Biomol Laboratories and other trending companies.